The fill-finish market—a traditionally stable one—is increasingly adopting new technologies. Research from our 12th Annual Report and Survey of Biopharmaceutical Manufacturing, and other studies ...
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Biologics Fill Finish Services Market Industry Trends and Global Forecasts to 2035, by Type of Primary Packaging Container, Type of Biologic Manufactured ...
The development of genetically engineered drugs is a relatively new endeavor. Insulin, as Humulin® from Eli Lilly & Co. and approved in 1982, was the first genetically engineered biopharmaceutical.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step. All drugs are subjected to regulatory scrutiny during the full development lifecycle because ...
DUBLIN--(BUSINESS WIRE)--The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results